DIVERSITY OF ANTI-NUCLEAR ANTIBODIES IN PROGRESSIVE SYSTEMIC-SCLEROSIS - ANTI-CENTROMERE ANTIBODY AND ITS RELATIONSHIP TO CREST SYNDROME

被引：556
|
作者：
TAN, EM
RODNAN, GP
GARCIA, I
MOROI, Y
FRITZLER, MJ
PEEBLES, C
机构：
[1] UNIV COLORADO,HLTH SCI CTR,DEPT MED,DIV RHEUMAT DIS,DENVER,CO 80202
[2] UNIV PITTSBURGH,SCH MED,DEPT MED,DIV RHEUMATOL & CLIN IMMUNOL,PITTSBURGH,PA 15260
来源：
ARTHRITIS AND RHEUMATISM | 1980年 / 23卷 / 06期
关键词：
D O I：
10.1002/art.1780230602
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：617 / 625
页数：9
相关论文
共 50 条
  • [21] Anti-centromere antibodies in 2 patients with discoid lupus erythematosus and no signs of systemic sclerosis
    Aragone, MG
    Balestrero, S
    Parodi, A
    Rebora, A
    ACTA DERMATO-VENEREOLOGICA, 1999, 79 (02) : 165 - 165
  • [22] SYSTEMIC SCLEROSIS - ATTACHMENT IN-VIVO OF ANTI-NUCLEAR ANTIBODY
    WANGEL, AG
    ODGERS, RJ
    AUSTRALASIAN ANNALS OF MEDICINE, 1970, 19 (01): : 67 - &
  • [23] Distinctive clinical phenotype of anti-centromere antibody-positive diffuse systemic sclerosis
    Caetano, Joana
    Nihtyanova, Svetlana, I
    Harvey, Jennifer
    Denton, Christopher P.
    Ong, Voon H.
    RHEUMATOLOGY ADVANCES IN PRACTICE, 2018, 2 (01) : 1 - 6
  • [24] THE DISTINCTIVE CLINICAL PHENOTYPE OF ANTI-CENTROMERE ANTIBODY-POSITIVE DIFFUSE SYSTEMIC SCLEROSIS
    Caetano, Joana
    Nihtyanova, Svetlana I.
    Denton, Christopher P.
    Ong, Voon H.
    RHEUMATOLOGY, 2017, 56 : 71 - 71
  • [25] Ability of anti-centromere and anti-topoisomerase antibodies to distinguish subsets of skin involvement in systemic sclerosis.
    Hudson, Marie
    Taillefer, Suzanne
    Steele, Russell
    Fritzler, Marvin
    Baron, Murray
    ARTHRITIS AND RHEUMATISM, 2006, 54 (09): : S482 - S482
  • [26] Clinicopathological characteristics of anti-centromere antibody-positive Sjogren's syndrome in the presence or absence of systemic sclerosis
    Suzuki, Yasunori
    Fujii, Hiroshi
    Mizushima, Ichiro
    Yamada, Kazunori
    Kawano, Mitsuhiro
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2018, 36 (03) : S281 - S281
  • [27] DISEASE PROGRESSION IN ANTI-CENTROMERE POSITIVE SYSTEMIC SCLEROSIS PATIENTS
    Hoekstra, E.
    Ahmed, S.
    Ueckert, D.
    Ajmone-Marsan, N.
    Kies, P.
    Ninaber, M.
    Heuvers, M.
    Geelhoed, J.
    Huizinga, T.
    Vries-Bouwstra, J. K. De
    ANNALS OF THE RHEUMATIC DISEASES, 2024, 83
  • [28] Disease Progression in Anti-Centromere Positive Systemic Sclerosis Patients
    Hoekstra, Eva
    Ahmed, S.
    Ueckert, David
    Marsan, Nina Ajmone
    Kies, Philippine
    Ninaber, M. K.
    Heuvers, Marlies
    Geelhoed, Miranda
    Huizinga, Thomas
    de Vries-Bouwstra, Jeska
    ARTHRITIS & RHEUMATOLOGY, 2024, 76 : 4972 - 4975
  • [29] The prognostic power of anti-topoisomerase I and anti-centromere antibodies in systemic sclerosis - A systematic review of the literature
    Hoekstra, E. M.
    Liem, S. I. E.
    Boonstra, M.
    Fehres, C. M.
    Schoones, J. W.
    Huizinga, T. W. J.
    de Vries-Bouwstra, J. K.
    SEMINARS IN ARTHRITIS AND RHEUMATISM, 2025, 72
  • [30] MYOCARDIAL INVOLVEMENT CHARACTERIZES EARLY SYSTEMIC SCLEROSIS WITH ANTI-SCL70 ANTIBODIES AND LONGSTANDING DISEASE WITH ANTI-CENTROMERE ANTIBODIES
    De Santis, M.
    Tonutti, A.
    Motta, F.
    Rodolfi, S.
    Monti, L.
    Francone, M.
    Selmi, C.
    ANNALS OF THE RHEUMATIC DISEASES, 2023, 82 : 988 - 989
12345